2021 annual financial data

Xeris Biopharma Holdings 2021 Net margin

Xeris Biopharma Holdings 2021 net margin with verified reported values.

Direct answer

Net margin was -247.48%.

Operating income was -115,156,000 USD and net income was -122,725,000 USD.
Operating cash flow was -95,535,000 USD.

Get free Xeris Biopharma Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
49,590,000 USD
Operating income
-115,156,000 USD
Net income
-122,725,000 USD
Operating cash flow
-95,535,000 USD